AFT Pharmaceuticals Limited

NZSE:AFT Stock Report

Mkt Cap: NZ$390.1m

AFT Pharmaceuticals Past Performance

How has AFT Pharmaceuticals performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


62.9%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: AFT has high quality earnings.

Growing Profit Margin: AFT's current net profit margins (12.1%) are higher than last year (8.9%).


Past Earnings Growth Analysis

Earnings Trend: AFT has become profitable over the past 5 years, growing earnings by 62.9% per year.

Accelerating Growth: AFT's earnings growth over the past year (60.2%) is below its 5-year average (62.9% per year).

Earnings vs Industry: AFT earnings growth over the past year (60.2%) exceeded the Pharmaceuticals industry 9.7%.


Return on Equity

High ROE: AFT's Return on Equity (29.2%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies